The Pacific Health Summit encourages individuals and organizations to partner across sectors to address the world’s greatest health challenges. Launched in 2010, the Summit Secretariat assembles a collection of specific proposals for cross-sectoral partnership. These “Calls” offer specific avenues of entry into targeted fields and clear contact points for immediate action.
While Calls for Collaboration primarily focus on the specific theme of the current year’s Summit, they may certainly touch upon any aspect of global health. “Calls” seek tangible ways to engage new partners through existing infrastructure and project mechanisms in order to facilitate immediate action. Previous "Calls" have resulted in numerous tangible, actionable partnerships that have made a proven impact in improving health outcomes around the globe.
2012 Calls for Collaboration
New working group on “smart risk-taking” around innovations in maternal and child health
Call for partners to join a new working group on “smart risk-taking” around innovations in maternal and child health to accelerate the incubation, adoption, and scale-up of innovative technologies in developing countries.
FROM | Absolute Return for Kids (ARK)
CONTACTS | Samukeliso Dube, Head of Health, Africa, email@example.com; Susannah Hares, Head of Innovation firstname.lastname@example.org
OVERVIEW | As organizations accelerate their
efforts to help achieve the Millennium Development
Goals, MCH challenges have come to the spotlight.
These challenges largely call not only for more
resources, but also for innovative technologies and
ways of programming, with a general recognition
that the development community’s current
approaches are not keeping up with the pace and
the nature of global change. To be truly innovative,
the sector needs to be more prepared to take risks
to identify and nurture solutions that are catalytic,
scalable, and sustainable. To shift the needle on
MCH, more high-risk investments with the potential
to deliver breakthrough solutions are essential.
However, investors and program implementers
alike seem to be more risk-averse than ever in the
MCH arena. Collaboration is therefore essential to
smartly manage high-risk, high-potential
investments and thus dilute risk for potential
investors and implementers.
ARK is seeking partners to be part of a working
group that will conceptualize new approaches to
innovation and risk-taking within MCH.
TARGET PARTICIPANTS | The private sector
(including the pharmaceutical and medical
equipment industries, commodity suppliers, and
the financial services sector); bilateral investors
and venture capitalists; and foundations, NGOs,
social enterprises, and academic institutions
NATURE OF COLLABORATION | The proposed
working group will share experiences, expertise,
and smart risk-taking methods to advance and
scale up innovations (technologies, business
models, and processes) for MCH for use in
developing countries. The working group will aim
to perform the following:
- Conceptualize, test, and disseminate new
approaches to risk-taking and identifying
breakthrough solutions to MCH.
- Share expertise and encourage collaboration.
- Encourage the development of multi-sectoral
alliances to find solutions and address key
- Build an evidence base of proven innovative
approaches to MCH.
- Develop tools to encourage and enable smart
risk-taking and conduct analyses of specific
- Write papers and present best practices at
various fora on MCH.1
We are also looking for evaluation data; specifically,
case studies and reports on successful innovative
interventions in MCH that have been implemented
in developing countries.
1 Some fora that have been identified for participation include the Global
Conference on Maternal and Child Health in Tanzania in 2013, the Women Deliver Conference in 2013, and the UN Commission on Life-Saving Commodities.
Share expertise in social business models and/or point-of-care
diagnostic tests to inform the introduction of POCTs
Call for partners to share expertise and experience in social business models and/or point-of-care
diagnostic tests (POCT) to inform the introduction of POCTs to pregnant women and babies in Peru
FROM | Brighter Futures Project, Universidad
Peruana Cayetano Heredia (Peru)
CONTACTS | Patricia J. Garcia, Principal Investigator for Brighter Futures Project and Dean of the School of Public Health and Administration, Universidad Peruana Cayetano Heredia, email@example.com
OVERVIEW | In 2011, the Universidad Peruana
Cayetano Heredia—with support from Grand
Challenges Canada—launched the Brighter
Futures Project, which focuses on maternal and
child health (MCH).1 The goal of Brighter Futures
is to address the unacceptably high burden of
maternal and child morbidity and mortality by
developing and evaluating a model to introduce
point-of-care diagnostic tests (POCT) to pregnant
women and children under one year of age. These
POCTs must be 1) sustainable and cost-effective,
and 2) effective and appropriate across the diverse
geographic and socioeconomic environments of
Peru—a country of coastal, jungle, and
mountainous regions that is home to very-low
income, low-income, and lower-middle income
We have collected initial information about the need
and willingness to pay for POCTs from community
members, local health providers, national health
experts, and entrepreneurs at the local and national
levels. The collaboration we propose would explore
innovative POCTs, as well as existing social
business models, designed to engage and benefit
local communities, which could be used to introduce
POCTs for MCH in Peru’s diverse settings.2
TARGET PARTICIPANTS | Experts in healthrelated
social business models and in the
development of POCTs; development agency
representatives; government and NGO leaders;
and business sector leaders, including developers
of diagnostics for human health
NATURE OF COLLABORATION | We invite
interested partners, including diagnostics
developers who would like their products to be part
of this business model, to join an international
advisory team focused on the implementation of
POCTs for MCH in Peru.
July 2012—September 2012
- Discussion of possible business models
- Discussion of POCT(s) to be included in model
September 2012—January 2013
- Virtual meetings for updates
- Sharing of experiences
1Every year more than half a million women die from pregnancy-related complications and 8.8 million children die before their fifth birthday, two thirds from infectious diseases. More than 90% of maternal and child
illnesses and deaths occur in developing countries.
2Social business, as first defined by Nobel Prize recipient Muhammad Yunus,
is a non-loss, non-dividend company designed to address a social objective.
Applications for funding from Global Impact’s Accelerator Fund
Call for applications for funding from Global Impact’s Accelerator Fund
FROM | Global Impact
CONTACTS | Scott Jackson, CEO, firstname.lastname@example.org; Teresa Connor, Vice President for Partnerships and Strategic Alliances, email@example.com
OVERVIEW | Global Impact recently launched its
Relief and Development Accelerator Fund, which
encourages initiatives that address the world’s
most pressing problems. The Accelerator Fund
will provide funding for international programs
targeted at improving the health of women and
girls, food security, education, and other issue
areas that represent the greatest potential to
sustainably promote physical and mental wellbeing.
In order to maximize results and encourage
partnerships, successful applicants to the
Accelerator Fund must obtain co-funding and
investments in their programs from other approved
sources that enable the applicant’s organization
to grow exponentially.
TARGET PARTICIPANTS | Nonprofit organizations
with international programming
NATURE OF COLLABORATION | Global Impact
seeks applications that focus on the following
- Economic development; particularly programs
that complement small business development
- Education at the pre- and primary school levels
with definitive goals
- Environmental sustainability and reversal of
- Food security and water purity
- Health and nutrition geared toward eliminating
- Women and children; particularly developing
women’s roles to create healthy economies
Call for applications for funding from Global Impact’s Accelerator Fund
Funding will be awarded to international programs
that represent the greatest potential to sustainably
promote physical and mental well-being and
leverage their Accelerator-awarded funds into
longer-term funding initiatives.
- Two levels of funding requests have been made
- Grants up to $35,000—applicants must
demonstrate a return on investment of 5:1
- Grants up to $50,000— applicants must
demonstrate a return on investment of 7:1
- Awarded funds may be used for dedicated
program staff, direct costs, new program
initiatives, co-funding requirements as
established by other funders for new and current
initiatives, or for increased capacity and
infrastructure over time.
- Funding must be matched in dollars by other
co-funders or internal sources.
- Projects should demonstrate potential for
leveraging Accelerator-awarded funds into
longer-term funding initiatives.
Global Impact will evaluate all applications and
notify applicants of their eligibility for funding by
June 30, 2012. This is an inaugural Accelerator
Fund round; we encourage organizations to send
a letter of interest if they are not able to meet the
June 30 deadline, given the timing of the Pacific
For a copy of the application, please email
Assess the impact, and inform the scale-up, of smartphone-based ultrasound
Call for partners to assess the impact, and inform the scale-up, of smartphone-based ultrasound
FROM | Mobisante Inc.
CONTACT | Sailesh Chutani, CEO, Mobisante Inc.,
OVERVIEW | Access to diagnostic ultrasound in
most emerging markets is still limited due to the
high cost, complexity, and bulk of existing devices.
This has adverse consequences on maternal and
fetal health, since many complications go
undetected during pregnancy. In addition, there is
also a missed opportunity to increase patient,
family, and community engagement in maternal
health by making pregnancy less “abstract” through
providing images that bring the baby to life
throughout the stages of pregnancy.
A smartphone-based ultrasound imaging system
exists that can be carried in a pocket, work off of
the electrical grid, and used by low- to mid-level
health professionals to acquire and send images
to remote experts for interpretation via cellular
networks. The device and system model has been
cleared by the U.S. Food and Drug Administration
and tested with hundreds of patients in Sierra
Leone and Nepal; it has proven effective at
detecting complications and providing routine
screening. Mobisante is searching for partners
interested in implementing the model at scale in
select regions and countries in order to establish
the effectiveness of the ultrasound imaging system
in reducing maternal and fetal mortality, and
increasing engagement by patients and families
in their healthcare. The results, if positive, could
be applied globally. The goal is to study and explore
the types of collaborations that could work to
facilitate the integration and adoption of this
technology, not to market or sell a specific device.
TARGET PARTICIPANTS | Local hospitals and
providers, ministries of health, academic
researchers, and healthcare delivery–focused
NGOs from any of the following regions: Africa,
Latin America, or Southeast Asia
NATURE OF COLLABORATION | Mobisante is
specifically looking for:
- Academic researchers to help fine-tune the
clinical study to adapt the system to the local
- Hospitals and providers to test the screening
service in their regions.
- Ministries of health to provide local and political
- NGOs to communicate with and build support
within the target communities.
Mobisante will provide the equipment and the knowhow
to build the systems and service at no charge
for this collaboration effort. The cycle is expected
to take 9–12 months.
Support from healthy priority-setting institutions for global and domestic health
technology assessment (HTA) systems
Call for partners from health priority-setting institutions to support global and domestic health
technology assessment (HTA) systems
FROM | The Center for Global Development (CGD)
and the National Institute for Health and Clinical
Excellence (NICE) International on behalf of the
CGD’s Working Group for Priority-Setting Institutions
for Global Health1
CONTACTS | Amanda Glassman, Director of
Global Health Policy & Research Fellow, CDG,
firstname.lastname@example.org; Kalipso Chalkidou,
Founding Director, NICE International, email@example.com
OVERVIEW | A fundamental challenge for all health
systems is to allocate finite resources across the
unlimited demand for health services. This is
ultimately a rationing problem because it requires
active or passive choices about what services are
provided to whom, at what time, and at whose
expense. Gains from reallocating toward more
cost-effective health interventions can be substantial,
illustrating the human and financial costs associated
with weak and implicit rationing institutions. Yet in
most countries, the rationing compromises under
the current implicit priority-setting mechanisms are
rarely made explicit to policymakers or the citizens
they serve. In response, CGD has formed a diverse
group of 30 experts to identify practical solutions
for resource allocation and priority-setting for health
technologies in low- and middle-income countries
(LMIC). Specifically, these recommendations are
1) a global HTA facility should be created to provide
technical and consultative support to global funding
agencies and LMIC governments, and 2) direct
support should be provided to LMICs that are
creating or growing their own HTA systems.
TARGET PARTICIPANTS | Leadership from
multilateral organizations, NGOs, donors, national
governments, and industry (technology developers,
private payers, and product development
partnerships) as well as HTA organizations and
ministries of health and finance
NATURE OF COLLABORATION | We invite
interested parties to share their time and expertise
in global health priority-setting through a forum for
partnership, starting with the establishment of an
interim secretariat for taking the recommendations
of the report further and for scoping out, in a
consultative fashion, an options analysis for
operationalizing the proposed HTA Global Facility.
Additionally, we are looking for:
- Several countries in which to pilot HTA
- Organizations that will lend their expertise and
capacity for improving accreditation and
resource allocation processes.
- Technical support from organizations currently
undertaking comparative effectiveness
assessment and HTA work in low- and middleincome
countries. This is to be done through
participating in the secretariat, implementing
there commendations, and volunteering
human resources through a peer-to-peer
1For more information regarding priority-setting institutions for Global Health,
Partner telecommunications providers with health insurance providers in Southeast Asia
Download the 2012 Calls for Collaboration Document.
Call for telecommunications providers to partner with health insurance providers in Southeast Asia
and Africa to develop new business models and payment collection solutions
FROM | PATH
CONTACTS | Kate Wilson, Senior Program Officer,
firstname.lastname@example.org; David Lubinski, Senior Adviser,
OVERVIEW | Globally, countries are expanding
health coverage to more of their citizens through
the development of national health insurance
schemes. While the strategies, policies, and
technologies used to support these schemes are
as varied as the countries implementing them, one
common challenge is continuously cited—the
facilitation of payments between citizens, providers,
and insurance funds.
In 2011, PATH and our partners, PharmAccess
Foundation and the Public Health Informatics
Institute, began working on information and
communication technology issues with ten
countries that are members of the Joint Learning
Network (JLN) for Universal Health Coverage.1
Member countries are in various stages of
implementing new health insurance information
systems, yet all of them are struggling with the
collection of micropayments and recurring
payments, particularly from citizens who may not
have a home address or stable employment. Our
project is working with JLN member countries now
to develop functional information system
requirements for various scenarios of payment
collection. It seeks to bridge this work into the
development of standard applications that can link
insurer platforms to mobile provider solutions.
Through this collaboration, we would propose
partnering with telecommunications providers to:
- Develop a better understanding of challenges
facing both parties.
- Specify some interoperability standards that
will work in multiple countries.
- Develop business model template(s)
that can be used by insurers or
telecommunications partners globally. The
intended result is a pilot of the model between
a network operator and one or more JLN
TARGET PARTICIPANTS | GSM Association mobile
payments and eHealth Working Group members,
JLN insurance provider representatives, International
Telecommunications Union members, World Bank
mobile payments, and health divisions
NATURE OF COLLABORATION | We invite
interested partners to join an international team that
would develop the following activities outlined below.
All facets of this collaboration are being designed
as a template that can be scaled up for broad-based
replication in other geographies and health domain
areas by organizations globally. We will provide free,
open access to all materials generated by the project
via the Web.
- Convene a small team of mobile payment,
ehealth, and insurance providers to develop
high-priority use-case studies and the technical
requirements for payments for insurance,
including interoperability needs.
- Develop and test, with network operators
and insurance providers, alternative
business models that are the most
attractive to both parties in the JLN
- Publish findings and models in a free,
open, online repository that is accessible
to all countries and operators.
- Disseminate vital information and case
studies to health policymakers and opinion
leaders directly and through partners, with
free, open access to all materials.
Host virtual meeting(s)
to review initial-use
cases and functional
for payment collection.
Host two-day meeting in
London to discuss
and agree upon
technical standards and
Pilot an example of
payment collection for
insurance in a JLN
member country. Issue
progress report and
1The Joint Learning Network (JLN) for Universal Health Coverage is a
resource for countries in the process of implementing universal health coverage (UHC). Current members include Bangladesh, Ghana, India, Indonesia, Kenya, Malaysia, Mali, Nigeria, the Philippines, South Africa, Thailand, and Vietnam. For more information, see JLN’s website, www.jointlearningnetwork.org.
2011 Calls for Collaboration
Evaluate a next-generation cold chain device
Call for partners to help evaluate next-generation cold chain device for improving vaccine storage capabilities.
FROM | Global Good, a program at Intellectual Ventures
OVERVIEW | Global Good is an Intellectual Ventures effort funded by the Bill & Melinda Gates Foundation to save lives in the developing world by inventing
technology-based solutions to global health and development challenges. We are seeking partners that have the vision and capacity to contribute to the
development of health technologies intended to accelerate achievement of the priorities of national health systems and the global health community.
The philanthropic Cold Chain Device project began in 2009 to support the priorities of the Bill & Melinda Gates Foundation. The passive cold chain
device represents a significant advancement over active vaccine cold chains because of its limited need for constant power supply and maintenance.
The current prototype stably stores vaccines for more than 90 days solely by using one set of reusable ice blocks.
TARGET PARTICIPANTS | EPI representatives, in-country NGOs, international organizations, healthcare workers
NATURE OF THE COLLABORATION | Global Good is exploring collaborations specific to in-country demonstrations and initial field testing of a
next-generation vaccine storage device. From a candidate pool of over ten countries, Global Good ultimately expects to choose two country partners to
advance to field testing that will provide data crucial to developing the final product to be adopted by national health systems.
Our intent is to work closely with partner countries to solicit direct feedback that will inform the design of the next generation of
devices. Field evaluations of our device will allow our team to engineer design improvements specific to a country or region's needs.
It will help us understand how our technology can help address current issues faced in vaccine logistics and contribute to increased
vaccine availability. Please note: There is no commitment for these initial locations to participate in future evaluations of the
device; we merely wish to demonstrate the vaccine container and explore whether there is a mutual fit for a follow-up field test.
June 24, 2011: Tour of Intellectual Ventures Laboratory and demonstration of cold chain device
June-August 2011: Visit ten or more candidate countries to demonstrate device and evaluate sites for field tests
August-September 2011: Limited field test in four countries
Late 2012: Scaled-up field tests in two countries
CONTACTS | Keith Schorsch, Vice President, Global Good, email@example.com
Craig Nakagawa, Director of Partner Development, Global Good, firstname.lastname@example.org
Nicole Bates, Global Good Program Manager, email@example.com
Share expertise to change social norms and promote immunization access and delivery
Call for industry, NGOs, and civil society organizations to share expertise to work with governments to support strategies that change social norms
and promote immunization access and delivery.
FROM | American Academy of Pediatrics (AAP), International Pediatric Association (IPA), and London School of Hygiene & Tropical Medicine (LSHTM)
OVERVIEW | Many partnerships are needed to tackle vaccine refusal by the public all over the world. Increasing public understanding of, and
dialogue about, the benefits and risks of immunization is a critical goal for all partnerships. Communication partnerships may improve responses to
anti-vaccination groups and immunization crises. Public-private partnerships are crucial to effectively addressing public distrust of vaccines bringing attention
on immunization goals. Engaging clinical child health leaders and pediatric professional organizations with other influential
stakeholders can open the door for stronger immunization advocacy around the long-term well-being of communities. International pediatric organizations (IPA) and
national associations have the depth and reach within countries across the globe to increase awareness of and access to immunization information and
positively impact decisionmaking by the public. All partners can support regional and country-specific commitments to greater advocacy, enhanced immunization
delivery, coverage improvement, and decreased vaccine-related injury.
TARGET PARTICIPANTS | Multinational business and NGO leaders; civil society, medical, and public health membership organizations; donor organizations; and ministries of health
NATURE OF COLLABORATION | Interested partners will convene at regional or selected national IPA meetings to engage in collaborative brainstorming and planning.
Meetings include, but are not limited to:
- AAP meeting and a joint meeting of the AAP and the EAP, October 2011, Boston
- Asia Pacific Congress of Pediatrics & Asia Pacific Nursing Conference, September 2012, Malaysia
- Association of Latin American Pediatric Organizations, November 2012, Ecuador
- Union of National African Pediatric Societies and Associations, 2012 (final date/location TBD)
- IPA Congress, August 2013, Melbourne, Australia
Discussions at these meetings will focus on how: immunization coverage can be increased by raising access, delivery system,
and financing goals to the level of a social movement; coordinated efforts can help overcome barriers to the public’s understanding
of immunization; improving and extending dialogue and advocacy might help build public confidence; and civil society
could create buy-in toward sustainable immunization advocacy goals. Meetings will also explore opportunities to create and adopt complementary,
integrated strategies to seek ministry of health and country commitments, raise professional awareness, and promote the value of immunization
goals to civil society leadership.
This project will drawn on three projects: (1) an effort by an IPA developing country immunization champion,
(2) LSHTM “Project to support Public Confidence in Immunization,” and (3)
an AAP scheme to engage advocates to support vaccine delivery and foreign aid for health infrastructure.
Sustainability of these collaborations is important for long-term success in supporting national immunization programs.
CONTACTS | Jonathan Klein, Associate Executive Director, AAP, firstname.lastname@example.org;
William Keenan, Executive Director, IPA, email@example.com;
Heidi Larson, Senior Lecturer, Dept. of Infectious Disease Epidemiology, LSHTM, firstname.lastname@example.org
Predict, prevent, and manage type 2 diabetes
Call for partners from all sectors to share expertise and experience in how mobile information systems can help predict, prevent, and manage type 2 diabetes
in underserved communities.
FROM | Swedish Medical Center and Pacific Northwest Diabetes Research Institute
OVERVIEW | In 2010 Swedish Medical Center, in conjunction with the Washington Global Health Alliance, Public Health - Seattle and King County,
and HealthPoint, launched the “Global to Local” program, which is initially focusing on culturally diverse communities near Seattle that have a health
status comparable to developing countries. The project seeks to develop new approaches to healthcare by adapting techniques and technologies created to
improve health in underserved communities in the developing world. Diabetes is a major focus of Global to Local due to its rising incidence in the United
States and around the globe. Smart phones and mobile devices are a central element of the strategy. The collaboration we propose explores the role for
mobile technology in helping address the issues of diabetes education, management, and prevention within a holistic approach to community-based health
and wellness (derived largely from global health work outside the United States).
TARGET PARTICIPANTS | Experts in type 2 diabetes, including practitioners and researchers; development agency representatives; government leaders;
NGOs; and the business sector, including leaders in developing information, communication, ICT, and diagnostic technologies applied to health.
NATURE OF COLLABORATION | We invite interested partners to join an international team of advisors who would participate in activities outlined below.
All facets of this collaboration are being designed as a template that can be scaled up for broad-based replication in other geographies and disease areas by
organizations globally. We will provide free, open access to all materials generated by the project via the Web.
- Assemble case studies on the use of IT, social media, diagnostic devices, health-based computer games, and other innovations in helping respond to the rise of non-communicable disease, especially type 2 diabetes, in developing and developed country environments.
- Build a free, open, online repository of case studies, as well as a catalog of relevant technologies, research strategies, and research findings.
- Help design research protocols for assessing the efficacy and cost-effectiveness of mobile health strategies that target type 2 diabetes.
- Disseminate vital information and case studies to health policymakers and opinion leaders directly and through partners, with free, open access to all materials.
Review of materials; initial case study and protocol collection and organization.
Virtual meeting to report on initial process.
Second progress report issued, including compendium of relevant resources.
CONTACTS | Dan Dixon, Executive Vice President, Swedish Medical Center, Dan.Dixon@swedish.org;
Jack Faris, CEO, Pacific Northwest Diabetes Research Institute, email@example.com
Submit proposals to the Immunization Innovation Fund
Download the 2011 Calls for Collaboration Document.
Call for partners to help shape the future of immunization systems through the Immunization Innovation Fund.
FROM | Optimize – a PATH/WHO collaboration
OVERVIEW | With the introduction of new vaccines come new challenges for immunization delivery. Previously, maintaining high stock
levels and tolerating high wastage rates was a tolerable way to overcome immunization system problems. This is no longer feasible with the
introduction of new, more costly vaccines that require an expanded storage capacity and need to be delivered to new target population groups.
In 2010, 250,000 doses of pentavalent vaccine expired in one country’s central store because the system charged with delivering these vaccines
was not ready. Close to US$1 million-worth of vaccines were lost. Another country was forced to delay its plans to introduce lifesaving new
vaccines because, to accommodate the introduction, it first had to expand its storage at the national level by ninefold. With these challenges come
opportunities to reexamine the systems trusted with delivering vaccines, and to actively seek out and develop innovative solutions.
PARTICIPANTS | Creative thinkers and problem solvers, including supply chain experts, technology wizards, scientists,
consumer goods and other distributors, vaccine developers and manufacturers, immunization program managers, staff from Ministries
of Health, Finance, Industry, Science, and Technology, industrial designers, and engineers.
NATURE OF THE COLLABORATION | The Gates Grand Challenges Explorations initiative is offering US$100,000 grants for unconventional ideas that address
gaps in immunization supply systems in order to transform how vaccines are delivered in the world's poorest countries. Successful projects will have the opportunity
to receive additional funding up to $1 million.
Proposals are sought that offer innovative approaches in the critical areas defined below:
1. Vaccine products and their packaging design, with characteristics that best suit the needs and constraints of low- and middle-income countries.
2. Better streamlining and integration of immunization supply systems with other health commodity supply chains where applicable and continued adaptation to
maximize efficiency, flexibility, and synergies with other public and private sector initiatives.
3. Assessment and minimization of the environmental impact of energy, materials, and processes used in immunization supply systems from the international to local levels.
4. Information systems to help staff plan and manage immunization activities and resources while ensuring that adequate quantities of vaccines are always available to meet demand.
5. Human resources policies and best practices to provide immunization supply systems with adequate numbers of competent, trained, motivated, and empowered personnel, at all levels
of the health system to overcome existing and emerging immunization supply challenges.
6. Innovative approaches to increasing immunization coverage through, for example, private sector opportunities, community-built solutions, and increased acceptance of immunization
by healthcare workers and parents.
Details and application information are online at: http://tinyurl.com/optimizesupplychains
The deadline for submissions is November 17, 2011.
CONTACT | Simona Zipursky, Policy and Advocacy Officer, PATH, firstname.lastname@example.org
2010 Calls for Collaboration
Bridge gaps between the private sector and civil society
Call for businesses to provide expertise and bridge gaps between the private sector and civil society through the
strategic placement of staff members for six-month “expert internships” in World Vision country offices in the developing world.
FROM | World Vision International
OVERVIEW | We are seeking interested business sector partners to collaborate in strategic areas on our
Child Health Now campaign and child health-focused program implementation. The goals of integrating staff from the business sector into our teams include:
- We will undoubtedly benefit enormously from the fresh perspective and strategic expertise of industry representatives “on loan.”
- We will develop a new appreciation for participating companies’ core competencies.
- Our multinational organization and its partners, as well as staff seconded from companies, will all have unique opportunities to
build new relationships with civil society and help bridge sector gaps in innovative ways.
TARGET PARTICIPANTS | Companies with expertise in market research, ICT, mHealth, and supply chain management, who would be willing
to lend one to three staff members to World Vision for six-month projects.
NATURE OF COLLABORATION | As part of corporate staff capacity-building, linked with corporate social responsibility, we seek to
collaborate with business partners in the strategic deployment of partnering company staff members for six months into World Vision teams
working in the areas outlined below. World Vision would cover office and travel costs during these secondments, but we hope that business
partners would cover salaries.
1NetHope is a collaboration of 30 of the world's leading international humanitarian organizations working together to solve
common problems in the developing world through corporate technology partnerships.
- Market Research and Evaluation Expertise for Global Campaign. We seek two to three staff members with Market Research & Evaluation
expertise, who would work with local campaign staff to co-develop an assessment framework for efforts in six selected countries
(Bolivia, Brazil, Armenia, Indonesia, India, and Kenya). The end product would be the development of metrics for measuring
successes and continued challenges.
- ICT and Mobile Health. We seek staff to help us adapt online learning for training and capacity-building using Web platforms that
target community health workers, in collaboration with WHO. Specifically, we are collaborating with NetHope1 and mHealth Alliance to bring to
scale a mobile health platform to support community health workers. We seek one staff member with extensive experience in the evaluation of
mobile health ICT systems solutions for deployment in challenging operational contexts. This individual would spend six months on a World
Vision team helping to develop internal evaluations and expertise.
- Lifesaving Supply Chains. We seek to partner with businesses with logistics and supply chain expertise in resource-constrained
settings to apply this expertise to help strengthen district health systems in collaboration with World Vision and local ministries of health.
Design, deploy, and test mobile information systems
Call for partners from all sectors to share their expertise with the Maternal and Newborn mHealth Initiative to help
design, deploy, and test mobile information systems in support of MNH.
FROM | mHealth Alliance, The Partnership for Maternal, Newborn & Child Health, PATH, White
Ribbon Alliance, BRAC, GSM Association, The Johns Hopkins School of Nursing and Bloomberg
School of Public Health, and Family Care International
OVERVIEW | Modern information and communications technologies (ICT), especially wireless, can help transform health outcomes.
A continuum of maternal and newborn care enabled by mobile ICT is critical to our achievement of MDGs 4 & 5 and will be an excellent
model for health systems strengthening for all diseases. The partners listed above have formed a new effort, the Maternal and Newborn
mHealth Initiative, which features a multi-pronged, global campaign of intensive consultations, solution development, and testing,
among other goals, to use ICT to:
- Ensure that the known and agreed high-priority MNH interventions are in fact carried out.
- Link providers with each other and to the data they need at each step in the care continuum.
- Provide health system administrators with accurate census and other data as well as management tools, and thus accountability.
TARGET PARTICIPANTS | MNH practitioners and academics, government leaders, NGOs, and the business sector.
NATURE OF COLLABORATION | The Initiative has five mutually supporting components, each with a global working group with which interested organizations can engage:
- Applying ICT to Priority Needs. In physical and virtual meetings over the next six months, this group will answer the question:
How can ICT, especially mobile, help meet the existing requirements of the MNH community?
- Design and Build System Strengthening Solutions. This group will design the Initiative’s first reference models of ICT and the content
and policies to go with them.1 These will be integrated, end-to-end systems along the continuum of care, designed to scale.
- Measurement and Evaluation. This group will design and seek consensus on the new M&E approaches that will be needed and possible.
- Trial Deployments of System Strengthening Solutions. Partners will survey current MNH ICT-supported projects, and then contribute
technology, content, and/or time and expertise to undertake trial deployments of the new solutions and test them.
- Communications. This group will build and manage the MNH Forum in the HUB—HealthUnBound virtual community—in part to create global
exposure and interactivity of the above four activities.
Drawing on the successful experience of other global health initiatives, the leadership of the Initiative will also develop principles
and guidelines for public-private partnerships in this field.
1Participants can contribute in one or more of four areas: information-sharing technology, content, diagnostic devices, and capacity-building.
Expand the introduction of fortified rice
Call for support to expand the introduction of fortified rice through the integration of Ultra Rice in food
distribution and feeding programs and by conducting market research and field trials to address existing knowledge gaps in rice fortification.
FROM | PATH
OVERVIEW | An estimated 2 billion people around the world suffer from iron deficiency, arguably the most easily preventable global
nutrition problem of our time. To address iron and other micronutrient deficiencies, PATH developed Ultra Rice®1 —a cost-effective,
customizable micronutrient delivery system that packs vitamins and minerals into rice grains made from rice flour with pasta-making
extrusion equipment. PATH transfers the Ultra Rice technology free of charge to manufacturers in developing countries, and these
local producers manufacture the Ultra Rice grains. Due to the heterogeneity of both rice markets and introduction pathways for
fortified rice around the world, diverse partnerships are required to make a tangible impact and scale up fortification.
TARGET PARTICIPANTS | NGOs, governments, market research firms, universities, and research groups. Food distributors, manufactures, and retailers in developing countries.
NATURE OF COLLABORATION | PATH invites implementation partners to join in the effort to commercialize and introduce fortified rice worldwide.
We are looking for partners that can engage in the activities outlined below at their own cost, with PATH providing technical assistance, linkages to
other key partners, and in-kind support.
1Ultra Rice resembles milled rice in size, shape, and color and is blended into traditional rice, typically at a 1:100 ratio.
Ultra Rice has been proven efficacious, shelf-stable, and acceptable to consumers in a wide range of geographies and demographic groups.
2"The Rice Fortification Research Group, a network of public and private entities, was recently established to advance
the rice fortification field by sharing knowledge and best practices with country implementers worldwide.
- Conduct Market Research to better understand rice supply chains and develop production and marketing strategies for fortified rice.
PATH has conducted research in limited markets, but is looking for additional research partners for other major rice consuming regions
(primarily Southeast Asia, West Africa, and Central and South America). Results from this data would be made widely available to stakeholders
in the field and disseminated through the Rice Fortification Resource Group.2
- Conduct Field Trials to further the evidence base by demonstrating the operational feasibility and biological impact of rice fortification
through various distribution channels and programmatic settings. Groups with funding to do this research (large-scale effectiveness studies or
efficacy studies in understudied demographic groups) would provide key contributions to the evidence base for fortified rice.
- Integrate Fortified Rice into feeding programs or poverty-focused distribution channels. Potential platforms for introduction include food aid
distribution programs, NGO or government feeding programs, or commercial channels that reach the poor. Programs that are looking to increase the
nutritional quality of their meals could procure Ultra Rice from PATH’s manufacturing partners and add it their rice-based meals.
Leverage core competencies for MNH awareness and advocacy campaigns
Call for business partners to leverage their core competencies in support of MNH awareness and advocacy campaigns.
FROM | White Ribbon Alliance and Maternal Mortality Campaign
OVERVIEW | The White Ribbon Alliance and Maternal Mortality Campaign promote access to quality health care for women worldwide,
working with organizations and individuals from a variety of sectors to use our collective voices and influence to stop women and
girls from dying needlessly in pregnancy and childbirth. Our supporters span the globe, linking all levels of society with one
guiding principle: play your part.
We ask businesses to join us by using your expertise, resources, and skills locally, nationally, and globally to help us take a message
of safe motherhood and child survival to those with the power to save lives.
We are proud of the many business partnerships that have already amplified campaigning awareness-raising and advocacy efforts.
Examples of past successful collaborations include:
- Elle magazine launched a photo shoot with Naomi Campbell to highlight International Women’s Day.
- Guardian Media Group and Vodafone both hosted dinners with influential women to bring attention to maternal health.
- May 1, 2010 marked the start of The Huffington Post’s “Countdown to Mother's Day,” featuring op-eds by maternal health champions.
- Myspace promoted the White Ribbon Alliance’s Million Mums campaign on Mother’s Day in 2008, with a sign-up facility, logo, and link on their “Causes” page. This significantly increased campaign sign-ups.
- The Times provided space for a one-page advertisement designed by MC Saatchi and promoted by Freud Communications
and Zenith Optimedia for the G8 in 2009.
TARGET PARTICIPANTS | Media sector and private companies
NATURE OF COLLABORATION | We ask businesses to look at the two ways they can make a real difference for maternal, newborn, and child health and could work with us in partnership:
1The Birth Atlas Project was created with support from Immpact, University of Southampton, The Partnership for Maternal, Newborn, and Child
Health, and the Norwegian Government.
- Awareness-Raising. Engage in joint activities with the White Ribbon Alliance, for example, by supporting the launch of our Birth Atlas Project1, which maps the state of
maternal health across the world.
- Advocacy Support. Provide advertising space in the form of print, television, and online media for key events, including the UN MDG Review Summit in September 2010.
Share data on successful, cost-effective MNCH interventions
Call for data on successful, cost-effective MNCH interventions delivered by frontline community health workers (case studies, project reports,
and outcomes data) to be made available through a free, open website.
FROM | RESULTS International
OVERVIEW | RESULTS International, an international advocacy organization, is seeking partners to work with us to identify the best examples
of successful, cost-effective MNCH interventions delivered by frontline community health workers, in rural or urban slum settings, to address the
leading causes of illness and disease among the bottom quintile in developing countries. Every bit of evidence counts.
The goal is to map initiatives with a demonstrated impact in improving the health of women and children in low-income settings, including
research projects and pilot studies that are underway. The collated information will be brought together on an open and freely-accessible website,
enabling policymakers and potential funders to identify the most successful and high-impact interventions that can be replicated or brought to scale
to accelerate progress on maternal, newborn, and child survival. Information can also be used by advocacy groups to understand and leverage greater
investment in proven interventions.
TARGET PARTICIPANTS | Research institutions, NGOs, UN agencies, donor agencies, governmental health agencies from countries with the highest
maternal, newborn, and child mortality rates, consultancy firms, and any private sector organizations (for example, pharmaceutical companies) that have
data demonstrating the success or challenges of community health interventions relating to maternal, newborn, and child survival.
NATURE OF COLLABORATION | In all examples, we are interested in quantitative data related to impact and costs:
- Case Studies and Project Reports on the deployment of trained, equipped, frontline community health workers.
For example, in Ethiopia trained frontline health workers are crucial in bringing care out of the clinic and into
rural villages and to fight against acute respiratory infections, malaria, and diarrhea, which are the leading causes
of child death. We are seeking similar small- or large-scale examples.
- Mechanisms for Real-Time Monitoring of Coverage and Impact of Interventions. For instance, the
Catalytic Initiative includes data reporting so that cost-effectiveness can be measured and mid-course corrections applied. Are there other examples?
- Data on Poverty-Targeted Interventions: Are there examples of programming that identify the very poor and tailor frontline
worker-focused interventions to reach these populations?
We are also looking for partners with technical website expertise to help build and organize the data into an open, free website.
Address distribution and innovation needs for MNH devices
Call for partners to help prioritize and address distribution and innovation needs for pharmaceutical formulations and devices in order to reduce newborn deaths from infections.
FROM | Saving Newborn Lives Program, Save the Children
OVERVIEW | Timely treatment with antibiotics would save the majority of newborn deaths due to serious infections (sepsis, meningitis, and pneumonia).
Currently, in the 68 highest burden countries fewer than one in four babies with serious infections are estimated to receive treatment. Successful
treatment requires the right antibiotics at the right time and place, the right dosage, and in some cases, the right device. Ongoing programs exist
within large potential markets (e.g., Ethiopia, Nigeria, Tanzania, Pakistan, India, Bangladesh, and Indonesia).
The WHO’s Essential Medicines for Children initiative is making progress in building private-public partnerships to advance solutions,
but the priority areas are not comprehensive, and the tracer medicines miss essential neonatal drugs.
Further innovation is required to overcome specific constraints for treating newborns, specifically gaps in devices, drug formulation, and availability. Gentamicin, the most commonly used
antibiotic for treating neonatal sepsis, is often available only in adult dose vials, increasing the risk of overdosing newborns, associated with
kidney and hearing damage. Injections to small babies require specific devices, such as 1 ml syringes and small bore needles, which are often unavailable.
Studies of the use of needle-free technology (Uniject®) and other innovations show potential to reach more babies at this critical time.
TARGET PARTICIPANTS | Private sector pharmaceutical and medical supply companies, and distributors or organizations with capacity in supply chain management.
NATURE OF COLLABORATION | WHO and the Saving Newborn Lives Program at Save the Children are undertaking trials of simplified antibiotic regimes
to evaluate treatment by community and other frontline workers in several countries. We are looking for partners to work with us in the following ways:
- Pharmaceutical Companies and Distributors to work with Save the Children and national partners over the next three years to conduct assessments and
prioritize and address gaps for specific formulations, forecasting, distribution, and reach for relevant antibiotics necessary for treating neonatal
infections in Ethiopia, Tanzania, Nigeria, Pakistan, India, and Indonesia (or subset of these).
- Medical Device Companies to partner with us, bringing R&D expertise to advance and evaluate innovations of diagnostics, drugs, and devices
to treat newborn infections in less developed countries.
Contribute to, shape, and mentor innovative technologies
Call for industry partners to contribute to, shape, and mentor innovative technologies to improve maternal and infant health through the Grand Challenges Explorations initiative.
FROM | Bill & Melinda Gates Foundation
OVERVIEW | In addition to the wide range of solutions that already exist to address MNH, new tools and technologies for early identification and prevention of dangerous conditions,
plus strategies to more rapidly diagnose and treat mothers and babies, are needed to achieve maximum health impact. New solutions are especially needed at the periphery of the health system—in
homes, communities, and primary clinics—where more than half the world’s births occur.
With this focus on the design, testing, manufacture, and launch of new technologies for “the frontline” we seek collaborations with private sector partners
through our Grand Challenges Explorations initiative.
Over the past three years, the Gates Foundation’s Grand Challenges Explorations has engaged thousands of scientists and engineers in over 130 countries
on a wide variety of topics, including vaccines, medical devices, contraceptive technologies, and diagnostics. To date, over 250 innovative ideas have been
supported by seed-stage grants of $100,000—with many awards going to both small and large companies. These initial projects are eligible to compete for a second
phase of funding of up to $1 million within the program.
TARGET PARTICIPANTS | We are seeking:
- Companies with experience in managing and harnessing R&D innovation.
- Companies with expertise in product lifecycle management and launch in new markets and consumer segments.
NATURE OF COLLABORATION | There are many ways for interested companies to collaborate:
- Join the Partnership Working Group or Grand Challenges Expert Review Committee for New Technologies to Improve the Health of Mothers and Newborns.
- Apply for Seed-Stage Funding for Your Own Idea through the Grand Challenges Explorations.
Develop mechanisms for registration and delivery of malaria treatment for pregnant women
Call for researchers, regulators, and policymakers to help develop mechanisms for registration and delivery of a novel, intermittent, preventive
treatment for malaria in pregnant women in sub-Saharan Africa efficiently and affordably.
FROM | Pfizer Emerging Markets Business Unit
OVERVIEW | Pfizer is working with Medicines for Malaria Venture and the London School of Hygiene & Tropical Medicine to develop a novel, intermittent,
preventive treatment for pregnant women (IPTp) to improve pregnancy outcomes for women in sub-Saharan Africa. Our focus is on malaria, which is a common cause of
preventable maternal and neonatal morbidity and mortality.1 The treatment features a fixed-dose combination of azithromycin and chloroquine (AZCQ) for IPTp.2
While IPTp has been adopted by 33 sub-Saharan countries, its acceptance remains quite limited and it is an unprecedented regulatory indication.
Pfizer seeks to collaborate with additional partners to ensure that in two-years’ time, when Phase III clinical trials are completed, the mechanisms
for efficient regulatory review are in place and that the treatment is available and accessible to those who need it most.3
TARGET PARTICIPANTS | Researchers and policymakers in the fields of malaria and reproductive health, as well as regulatory agencies from sub-Saharan Africa,
global health funding agencies (including H8 organizations), and civil society.
NATURE OF COLLABORATION | We invite interested partners to share their time and expertise to help develop proposals for mechanisms for:
1According to WHO, approximately 120 million pregnancies are at risk of malaria each year, and about 36 million of them are in sub-Saharan Africa.
2While WHO recommends sulfadoxine-pyrimethamine (SP) for IPTp, emergence of resistance has become a cause of concern. Finding alternatives to SP is an
urgent priority and there are few drugs in the pipeline.
3An independent data-monitoring committee of malaria experts is overseeing the trials.
- Expedited, thorough, and simultaneous review and approval of a regulatory dossier for a product that is developed exclusively for countries in sub-Saharan Africa.
- Ensuring uninterrupted product distribution to antenatal clinics in sub-Saharan Africa.
- Ensuring access of IPTp treatments (like AZCQ) to women at affordable prices, through mechanisms somewhat similar to the AMFm (Affordable Medicines Facility for malaria)
mechanism for ACT antimalarials.
- Improving acceptability of IPTp regimen by healthcare professionals and pregnant women in sub-Saharan Africa.
Highlight the business sector's work in MNH in two online communities
Call for business partners engaged in MNH to highlight their work and organizations in two online communities to grow networks, avoid duplication, and link efforts.
FROM | Maternal Health Task Force and Save the Children
OVERVIEW | Thanks to the efforts of numerous individuals and organizations, MNH has risen to the top of the global health agenda in 2010. Now more than ever,
it is critical for organizations to link efforts and capacity so that the MNH community can see who is doing what, where, and how we can help one another. Two online
communities and information sources exist to do just this, and in 2010 the communities seek to incorporate the work and perspective of the business sector.
TARGET PARTICIPANTS | Businesses working to improve MNH through the production of goods and services, research, knowledge-sharing mechanisms, or training.
NATURE OF COLLABORATION | Below please find numerous opportunities to link to different groups and highlight your organization. None of these opportunities
carries any fee or cost. The goal is simply to welcome new partners to these ongoing dialogues that are accelerating progress in MNH.
- Connect with Colleagues and Highlight Your Organization’s Work through Healthy Newborn Network (HNN), a global online community of newborn health researchers,
policymakers, program managers, practitioners, advocates, or company representatives—whose work benefits newborn health. The network provides an entry point for those
who wish to interact with professionals around the world to comment on and rate resources available. Additionally, it allows organizations to create their own Partner
Page to highlight their own programs and resources in newborn health.
- Link to Some 40 Organizations Working in Maternal Health through the Maternal Health Taskforce (MHTF) Partner Channel and Map:
- Create an organization page on the MHTF’s Partner Channel, which highlights the important work that leading organizations are doing in maternal health
and is a forum for institutional knowledge-sharing across sectors.
- Map your maternal health project or organization on the MHTF map to make your organization and its work highly visible to a wide network of partners.
Manufacture and distribute two appropriate, durable medical devices
Call for partners to collaborate with an existing NGO-commercial company partnership to manufacture and distribute two appropriate,
durable medical devices that directly impact MNH in low-resource settings.
FROM | Powerfree Education and Technology (PET) and Freeplay Energy1
OVERVIEW | Most hospitals, especially in developing countries, have a “graveyard” of medical technology not used because it is too complex,
or not working because of lack of maintenance or replacement parts. To save lives and be effective, technology must be targeted at the right health
challenges, affordable, available where the needs are greatest, and fit for purpose. Over the last five years, two appropriate technology medical
devices have been developed, each with a menu of power options:
- Doppler Fetal Heart Rate Monitors help identify babies in distress, addressing a need for reducing intrapartum stillbirths and neonatal
deaths from labor complications. The device won the INDEX global design award in 20092, and while manufacturing has commenced, distribution
requires wider partnerships, especially to reach low- and middle-income countries.
- Pulse Oximeters (SPO2) identify low oxygen levels in the blood and have become standard care for preterm/ill newborns, children with
pneumonia, women having a C-section, or anyone administered an anaesthetic. Without this technology, sick babies who need oxygen may not be
identified, or babies may be given too much oxygen, which can cause permanent damage. WHO has identified an immediate need for approximately
100,000 SPO2 monitors;3 the monitors could be manufactured at about 75 percent lower cost with further development of the electronics.
TARGET PARTICIPANTS | Partners with expertise in distribution and R&D for medical devices in low-income settings, including medical
equipment manufacturers, distributors, and humanitarian/ philanthropic foundations.
NATURE OF COLLABORATION | With the goal of developing, manufacturing, and distributing fit-for-purpose and essential life-saving medical
technologies to impact maternal, newborn, and child survival in high-burden countries, we seek new collaborators to join our partnership and work with us on:
1PET, a non‐profit, is based in South Africa. Freeplay Energy is a commercial company.
2One of the key innovations noted by the INDEX prize was the variety of power options available: wind-up, foot pump,
and solar panel, or by AC mains electricity if possible. This is especially crucial in sub-Saharan Africa and South Asia, given unreliable electrical
power, dust, humidity, and other challenges.
3This need was identified through WHO‘s “Safe Surgery Saves Lives” initiative.
- Refinement of the current versions of the fetal heart rate monitor and pulse oximeter devices to be suitable for manufacture in large quantities and at lower cost.
- Distribution to ensure these new devices reach the settings where they are needed most at affordable cost.
- Linked Distribution of Distance Learning Materials to improve quality of care when using the devices.
Share expertise on implementing innovations at scale
Download the 2010 Calls for Collaboration Document.
Call for industry partners to share their expertise on implementing innovations at scale, in collaboration with the Implementation Support Network, which supports the effective
scale-up and delivery of maternal and newborn interventions and builds capacity of local practitioners in the field.
FROM | Averting Maternal Death and Disability (AMDD), Mailman School of Public Health, Columbia University
OVERVIEW | The global health community has identified and reached consensus on the most effective interventions to significantly decrease maternal and newborn deaths,
and these interventions are generally well-reflected in national policies. However, the translation of national strategies into sustainable actions at regional and district levels
remains inadequate. AMDD is working with UNICEF and UNFPA to develop an Implementation Support Network (ISN) that will partner with and support ministries of health to implement
maternal and newborn health (MNH) interventions at scale. One goal of this ISN is to develop an implementation resource toolkit for select countries in sub-Saharan Africa and South
Asia. The toolkit would support, for example, capacity-building of local practitioners and institutions within the ISN and include an approach to implementation that is flexible and
adaptable for a variety of settings.
The engagement of the business sector would help the ISN and the Ministries of Health it supports to move innovation more quickly and efficiently across systems.
We are asking companies to help us develop practical, on-the-ground delivery approaches to implementation of MNH interventions.
TARGET PARTICIPANTS | Companies and organizations with expertise in rolling out services and products in resource-constrained settings and complex situations,
with particular experience in developing new mechanisms for the implementation of products and services.
NATURE OF COLLABORATION | We invite interested partners to share their time and expertise on change-management practices, new product and services rollout processes, and
related staff development, through three to five consultations over six months to help the ISN provide creative solutions to ministries of health. In particular, we seek
partners to work with us to:
- Identify Necessary Steps for Ministries of Health in selected countries to move to national scale on delivery of core maternal health interventions
(steps that address transport and human resource constraints, for example).
- Develop In-Country and Intervention-Specific Tools for strengthening the core competencies related to basic management practices that are necessary to execute the above steps.
- Identify and Prioritize New Approaches to the Use of Technology to support implementation for the above steps.
- Recommend Strategies to Facilitate Collaboration and knowledge sharing amongst practitioners at the district level to accelerate successful implementation practices.
The end product of this collaboration will be an implementation toolkit that is flexible and adaptable for a variety of settings.